HEMORRHAGIC PLEURAL EFFUSION IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA ON IBRUTINIB THERAPY

被引：1
作者：
Ali, Fatima
Wiley, Joan
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
MANAGEMENT;
D O I：
10.1016/j.chest.2022.08.1190
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1415A / 1415A
页数：1
相关论文
共 3 条
  • [1] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) : 2425 - 2437
  • [2] Management of adverse effects/toxicity of ibrutinib
    Paydas, Semra
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 136 : 56 - 63
  • [3] Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies
    Shatzel, J. J.
    Olson, S. R.
    Tao, D. L.
    McCarty, O. J. T.
    Danilov, A. V.
    DeLoughery, T. G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 835 - 847
1